LINC-PINT and neuroblastoma: To test whether this decrease could be mediated by LINC‐PINT, we modeled its neuronal knockdown by administering LINC‐PINT‐targeted GapmeRs (Qiagen) to the human neuroblastoma cell line SH‐SY5Y.